Skip to Content
  • Revenues ($M)$9,968
  • Revenue Percent Change-41.3%
  • Profits ($M)$968
  • Profits Percent Change-61.2%
  • Assets ($M)$20,975
  • Employees49,400
  • Market Value — as of March 31, 2016 ($M)$22,601
  • Previous Rank185
  • Morning Consult Brand Index
    C

The biotech healthcare company makes devices and pharmaceuticals that treat hemophilia, immune disorders, infectious diseases, and kidney disease.

Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Company Info

CEO
Jose E. Almeida
Sector
Health Care
Industry
Medical Products and Equipment
HQ Location
Deerfield, IL
Websitehttp://www.baxter.com
Years on Fortune 500 List22
Employees49,400
Spun off Baxalta (2015 rank: 420), July 1, 2015.

Key Financials (last fiscal year)

$ millions% change
Revenues ($M)$9,968-41.3%
Profits ($M)$968-61.2%
Assets ($M)$20,975-
Total Stockholder Equity ($M)$8,846-
Market Value — as of March 31, 2016 ($M)$22,601-

Profit Ratios

Profit as % of Revenues9.7%
Profits as % of Assets4.6%
Profits as % of Stockholder Equity10.9%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)1.76
EPS % Change (from 2014)-61.4%
EPS % Change (5 year annual rate)-5.9%
EPS % Change (10 year annual rate)1.5%

Total Return

Total Return to Investors (2015)-2.7%
Total Return to Investors (5 year, annualized)9.3%
Total Return to Investors (10 year, annualized)8.7%